Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Phase 1 × Lymphoma, B-Cell × Cisplatin × Clear all

Phase

Phase 1/2 2 Phase EARLY_PHASE1 1 Phase 3 1 Phase 1 1

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Conditions

Carcinoma, Non-Small-Cell Lung 67 Neoplasms 41 Squamous Cell Carcinoma of Head and Neck 39 Head and Neck Neoplasms 33 Lung Neoplasms 32 Uterine Cervical Neoplasms 26 Stomach Neoplasms 24 Ovarian Neoplasms 24 Unspecified Adult Solid Tumor, Protocol Specific 22 Neoplasm Metastasis 21 Small Cell Lung Carcinoma 19 Pancreatic Neoplasms 18 Colorectal Neoplasms 17 Esophageal Neoplasms 15 Cholangiocarcinoma 15 Carcinoma, Squamous Cell 15 Breast Neoplasms 15 Mesothelioma, Malignant 14 Melanoma 12 Fallopian Tube Neoplasms 11 Carcinoma, Ovarian Epithelial 11 Urinary Bladder Neoplasms 10 Mesothelioma 10 Sarcoma 9 Gallbladder Neoplasms 9 Biliary Tract Neoplasms 9 Esophageal Squamous Cell Carcinoma 8 Carcinoma 8 Peritoneal Neoplasms 7 Colonic Neoplasms 7

Interventions

Cyclophosphamide 36 fludarabine 28 Rituximab 25 obinutuzumab 10 fludarabine phosphate 9 Bendamustine Hydrochloride 9 pembrolizumab 7 Vincristine 6 Specimen Handling 6 Prednisone 6 Magnetic Resonance Spectroscopy 6 Leukapheresis 6 Lenalidomide 6 Etoposide 6 venetoclax 5 ibrutinib 5 Inotuzumab Ozogamicin 5 Doxorubicin 5 Biopsy 5 ublituximab 4 tazemetostat 4 glofitamab 4 Interleukin-2 4 polatuzumab vedotin 3 Radiation 3 Nivolumab 3 Ipilimumab 3 Immunotherapy, Adoptive 3 Gemcitabine 3 Dexamethasone 3

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT02741388 2021-12-07

SELINDA

The Lymphoma Academic Research Organisation

Phase 1 Completed

Lymphoma, Lymphoma, B-Cell

Data powered by HemOnc (CC BY 4.0) Colophon ⚡